[FATE] YoY Quarter Result on 30-Sep-2024 [#Q3]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
12-Nov-2024
Financial Year
2024
Quarter
30-Sep-2024 [#Q3]
Profit Trend
QoQ- -24.07%
YoY- -5.55%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 3,074 1,944 14,981 14,225 7,558 2,429 1,026 20.04%
PBT -47,678 -45,170 -83,563 -43,308 -58,684 -26,609 -16,782 18.98%
Tax 0 -4,740 -2,828 -11,315 0 910 339 -
NP -47,678 -45,170 -80,735 -43,308 -58,684 -26,609 -16,782 18.98%
Tax Rate - - - - - - - -
Total Cost 50,752 47,114 95,716 57,533 66,242 29,038 17,808 19.05%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -1,551.01 -2,323.56 -538.92 -304.45 -776.45 -1,095.47 -1,635.67 -0.88%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.40 -0.46 -0.83 -0.45 -0.68 -0.40 -0.31 4.33%
EPS Diluted -0.40 -0.46 -0.83 -0.45 -0.68 -0.40 -0.31 4.33%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.